Last reviewed · How we verify
NCT04829994
Post-Market Clinical Follow-Up onTVT EXACT® Continence System
trial testing Intervention in Stress Urinary Incontinence in 198 participants. Participants enrolled and being followed up; not accepting new ones.
30 September 2035
Quick facts
| Lead sponsor | Ethicon, Inc. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 198 |
| Start date | 8 July 2021 |
| Primary completion | 30 September 2035 |
| Estimated completion | 28 February 2036 |
| Sites | 8 locations across France, Denmark, Austria, Sweden, Germany, United States |
Drugs / interventions tested
- Intervention
Conditions studied
- Stress Urinary Incontinence — all drugs for Stress Urinary Incontinence →
Sponsor
Ethicon, Inc. — full company profile →
Who can join
21 and older, female only, with Stress Urinary Incontinence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this single arm, post market, clinical study is to evaluate the performance of Gynecare TVT EXACT® Continence System in women undergoing retropubic mid-urethral sling surgery for Stress Urinary Incontinence (SUI).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04829994
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Intervention
Trials testing the same drug.
- NCT07038317 — A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status · NA · not yet recruiting
- NCT06112431 — Eye Health Intervention Study in Upper Manhattan · NA · not yet recruiting
- NCT07202390 — Intraarticular Gold Microparticles for Knee Osteoarthritis · NA · not yet recruiting
- NCT07444736 — Effect of 8 Weeks of Resistance Training With Blood Flow Restriction on Muscle Strength, Clinical Parameters, Biochemica · NA · enrolling by invitation
- NCT07376668 — Effects of a WhatsApp-assisted Prehabilitation for Patient Undergoing Elective Colorectal Cancer Surgery · NA · not yet recruiting
Other recruiting trials for Stress Urinary Incontinence
Currently open trials in the same condition.
- NCT06706362 — Assessing the Utility of Prophylactic Antibiotics at Time of Urethral Bulking Using Bulkamid (Bulkamid Study) · Phase 4 · recruiting
- NCT06924450 — Effect of Modified Mesh on Surgical Success in Transobturator Tape Surgery · NA · recruiting
- NCT06840093 — Outcomes of Limited Postoperative Restrictions Following Sling Placement: A Randomized Controlled Trial · NA · recruiting
- NCT06111209 — The Anabolic Effect of Testosterone on Pelvic Floor Muscles · Phase 2 · recruiting
- NCT06731985 — The Follow-up After Shorter Tapes Study. Effectiveness and Safety of Shorter Trans-obturator Tapes. · recruiting
Other Ethicon, Inc. trials
Trials by the same sponsor.
- NCT06664788 — A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery · NA · recruiting
- NCT05299606 — POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) · NA · terminated
- NCT04829175 — Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry · recruiting
- NCT04889989 — Microwave Ablation in Chinese Patients With Lung Tumors · NA · terminated
- NCT04829058 — GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04829994 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ethicon, Inc.
- Last refreshed: 13 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04829994.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing